BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22358181)

  • 21. Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature.
    Liu S; Zhong Z; Xiao M; Song Y; Zhu Y; Hu B; Sun Z; Yi W; Peng C
    BMC Gastroenterol; 2020 Nov; 20(1):399. PubMed ID: 33238879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features of combined hepatic carcinoma].
    He C; Yin HF; Liu P; Zhang Y; Zhang JB
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
    Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
    J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
    Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
    World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.
    Goeppert B; Frauenschuh L; Renner M; Roessler S; Stenzinger A; Klauschen F; Warth A; Vogel MN; Mehrabi A; Hafezi M; Boehmer K; von Deimling A; Schirmacher P; Weichert W; Capper D
    Mod Pathol; 2014 Jul; 27(7):1028-34. PubMed ID: 24309328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
    Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
    Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
    Zen Y; Britton D; Mitra V; Pike I; Sarker D; Itoh T; Heaton N; Quaglia A
    Histopathology; 2014 Dec; 65(6):784-92. PubMed ID: 25039376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary neoplasm of the bile duct accompanying biliary mixed adenoneuroendocrine carcinoma.
    Onishi I; Kitagawa H; Harada K; Maruzen S; Sakai S; Makino I; Hayashi H; Nakagawara H; Tajima H; Takamura H; Tani T; Kayahara M; Ikeda H; Ohta T; Nakanuma Y
    World J Gastroenterol; 2013 May; 19(20):3161-4. PubMed ID: 23716999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.
    Sato H; Nakanuma Y; Kozaka K; Sato Y; Ikeda H
    Int J Clin Exp Pathol; 2013; 6(2):318-22. PubMed ID: 23330019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
    Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
    World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF; Frank R; Zhang PJ; Furth EE
    Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma.
    Goere D; Wagholikar GD; Pessaux P; Carrère N; Sibert A; Vilgrain V; Sauvanet A; Belghiti J
    Surg Endosc; 2006 May; 20(5):721-5. PubMed ID: 16508808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas.
    Karamitopoulou E; Tornillo L; Zlobec I; Cioccari L; Carafa V; Borner M; Schaffner T; Brunner T; Diamantis I; Zimmermann A; Terracciano L
    Am J Clin Pathol; 2008 Nov; 130(5):780-6. PubMed ID: 18854271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Clinicopathological Features of Biliary Neuroendocrine Carcinoma with Adenocarcinoma.
    Shiihara M; Higuchi R; Furukawa T; Yazawa T; Uemura S; Izumo W; Yamamoto M
    Dig Surg; 2021; 38(1):30-37. PubMed ID: 32570243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.
    Mosnier JF; Kandel C; Cazals-Hatem D; Bou-Hanna C; Gournay J; Jarry A; Laboisse CL
    Mod Pathol; 2009 Feb; 22(2):182-90. PubMed ID: 18622386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
    Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Azuma T; Itoh T; Ku Y; Zen Y
    Mod Pathol; 2017 Jul; 30(7):986-997. PubMed ID: 28338651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricellulin expression and its prognostic significance in primary liver carcinomas.
    Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.
    Kano Y; Kakinuma S; Goto F; Azuma S; Nishimura-Sakurai Y; Itsui Y; Nakagawa M; Kudo A; Tanabe M; Kirimura S; Amano T; Ito T; Akashi T; Asahina Y; Watanabe M
    Clin J Gastroenterol; 2014 Oct; 7(5):449-54. PubMed ID: 26184027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.